Depressive symptoms in healthy apolipoprotein e e4 carriers and noncarriers: A longitudinal study

Journal of Clinical Psychiatry

Volumn 74, Issue 12, 2013, Pages 1256-1261

  Locke, Dona E C ^a,b   Dueck, Amylou C ^a   Stonnington, Cynthia M ^a   Knopman, David S ^a   Geda, Yonas E ^a   Caselli, Richard J ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BECK DEPRESSION INVENTORY; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG USE; FEMALE; FOLLOW UP; GENOTYPE; GERIATRIC DEPRESSION SCALE; HAMILTON SCALE; HETEROZYGOTE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; PERSONALITY ASSESSMENT INVENTORY; PRIORITY JOURNAL; SYMPTOM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; APOLIPOPROTEIN E4; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; INTELLIGENCE TESTS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERSONALITY ASSESSMENT; PSYCHIATRIC STATUS RATING SCALES;

EID: 84891480376     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08564     Document Type: Article

References (22)

1. Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol. 2004;61(8):1290-1293.
2. Panza F, Frisardi V, Capurso C, et al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry. 2010;18(2):98-116.
3. Mackin RS, Insel P, Aisen PS, et al; Alzheimer?s Disease Neuroimaging Initiative. Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years. Int J Geriatr Psychiatry. 2012;27(4):355-363.
4. Steenland K, Karnes C, Seals R, et al. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer?s disease in 30 US Alzheimer?s disease centers. J Alzheimers Dis. 2012;31(2):265-275.
5. Geda YE, Knopman DS, Mrazek DA, et al. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol. 2006;63(3):435-440.
6. Panza F, D?Introno A, Colacicco AM, et al; Italian Longitudinal Study on Aging Working Group. Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian Longitudinal Study on Aging. Dement Geriatr Cogn Disord. 2008;25(4):336-346.
7. Caselli RJ, Dueck AC, Osborne D, et al. Longitudinal modeling of age-related memory decline and the APOE e4 effect. N Engl J Med. 2009;361(3):255-263.
8. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62.
9. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
10. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982-1983;17(1):37-49.
11. Morey L. Personality Assessment Inventory: Professional Manual. Lutz, FL: Psychological Assessment Resources; 1991.
12. Caselli RJ, Reiman EM, Osborne D, et al. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology. 2004;62(11):1990-1995.
13. Caselli RJ, Reiman EM, Locke DEC, et al. Cognitive domain decline in healthy apolipoprotein E e4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol. 2007;64(9):1306-1311.
14. Folstein MF, Folstein SE, McHugh PR. ?Mini-mental state?: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
15. Pfeffer RI, Kurosaki TT, Harrah CH Jr, et al. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323-329.
16. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3): 179-186.
17. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer?s disease: recommendations from the National Institute on Aging-Alzheimer?s Association workgroups on diagnostic guidelines for Alzheimer?s disease. Alzheimers Dement. 2011;7(3):263-269.
18. Richard E, Reitz C, Honig LH, et al. Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol. 2013;70(3):383-389.
19. Caselli RJ, Reiman EM, Hentz JG, et al. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes. Sleep. 2002;25(4):447-453.
20. Stonnington CM, Locke DEC, Dueck AC, et al. Anxiety affects cognition differently in healthy apolipoprotein E e4 homozygotes and noncarriers. J Neuropsychiatry Clin Neurosci. 2011;23(3):294-299.
21. Stonnington CM, Snyder PJ, Hentz JG, et al. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-e4 carriers. J Clin Psychiatry. 2009;70(10):1379-1384.
22. Caselli RJ, Locke DEC, Dueck AC, et al. The neuropsychology of normal aging and preclinical Alzheimer?s disease [published online ahead of print March 26, 2013]. Alzheimers Dement.